FDA Amends Emergency Use Authorizations for Zanamivir and Oseltamivir Phosphate

Summary

The Food and Drug Administration (FDA) has updated its emergency use authorizations for antiviral medications zanamivir and oseltamivir phosphate, which were initially granted in 2009 to combat certain viral diseases, following requests from the Centers for Disease Control and Prevention (CDC).